Abstract:Abstract Abstract 3093 Poster Board III-30 The side population (SP) phenotype, defined as the verapamil-blockable ability to efflux the nucleic acid dye Hoechst 33342, has been used to enrich for stem cells in several human normal tissues, cancers, and multiple cell lines including blood cells, and thus may be useful for the identification and isolation of cancer stem cells, which has emerged as a new therapeutic target for cancer treatment. However, the molecular mechanism(s) operating in SP cells remain unclear. Previous studies show that the stem cell factor, SALL4 plays a central role in the self-renewal of embryonic and leukemic stem cells. In this study, we determined the role of SALL4 in side population (SP). Using FACS sorting, we found the presence of SP fractions in four leukemic cell lines: HL-60, NB-4, RPMI8226 and KG1a. SALL4 expression was more abundant in SP cells compared with non-SP cells by 2- 4 fold in these leukemic cell lines. Knockdown of SALL4 in purified SP cells resulted in a reduction of SP population, indicating that SALL4 is required for the self-renewal of SP cells in this culture system. Since the side population phenotype is known to be mediated by the ATP-binding cassette proteins, we further investigated whether SALL4 could regulate the ATP transporters in SP cells. Chromatin immunoprecipitation (ChIP), luciferase assays and real-time PCR analysis demonstrated that SALL4 could bind to the promoter region of ABCA3, one of the ABC transporters, and activated its expression. In addition, while overexpression of SALL4 led to drug resistance in cell lines, SALL4-knockdown cells displayed more sensitive to drug treatments than the control cells. Further more, SALL4 expression was associated with primary AML treatment status (N= 64 cases), with higher SALL4 mRNA expression seen in drug resistance and partial remission patients than that from complete remission cases. Taken together, our results suggest that SALL4 plays an important in the sensitivity to drug treatment, at least in part, through the maintenance of SP cells, and is responsible for drug-resistance in leukemia. Disclosures No relevant conflicts of interest to declare.

The Transcription Factor Spalt and Human Homologue SALL4 Induce Cell Invasion Via the Dmyc-Jnk Pathway in Drosophila

Spindle Pole Body Component 24 Homolog Potentiates Tumor Progression Via Regulation of SRY-box Transcription Factor 2 in Clear Cell Renal Cell Carcinoma.

The Invasion and Metastasis of Colon Adenocarcinoma (COAD) Induced by SALL4

SALL4, a Novel Oncogene Induces Myelodysplastic Syndrome and Acute Myeloid Leukemia Via Wnt/β-Catenin Pathway.

CtBP Modulates Snail-mediated Tumor Invasion in Drosophila.

SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and inducesAML in transgenic mice

The new advance of SALL4 in cancer: Function, regulation, and implication

SALL4: an emerging cancer biomarker and target.

A SALL4/MLL/HOXA9 Pathway in Murine and Human Myeloid Leukemogenesis.

Leukemic Survival Factor Sall4 Contributes to Defective Dna Damage Repair

Myc Suppresses Tumor Invasion and Cell Migration by Inhibiting JNK Signaling.

Sall4 is A New Target in Endometrial Cancer

Sall4, a Stem Cell Factor, Promotes Chemoresistance by Regulates the Side Population Cell Phenotype.

Zinc Finger Protein SALL4 Functions through an AT-Rich Motif to Regulate Gene Expression

SALL4, a Novel Marker for Human Gastric Carcinogenesis and Metastasis.

Rho1–Wnd Signaling Regulates Loss-of-cell Polarity-Induced Cell Invasion in Drosophila

SALL4 Activates TGF-beta/SMAD Signaling Pathway to Induce EMT and Promote Gastric Cancer Metastasis

Slc39a4 Expression Is Associated With Enhanced Cell Migration, Cisplatin Resistance, And Poor Survival In Non-Small Cell Lung Cancer

Wingless Modulates Activator Protein-1-mediated Tumor Invasion

Dglyat Modulates Gadd45-mediated JNK Activation and Cell Invasion

Hippo Signaling Promotes JNK-dependent Cell Migration